Subsidies for the Basque Companies .

Filtra tu búsqueda

VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities
05/12/2024 Funding

VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities

Support the execution of a robust pipeline of customer projects for innovators developing groundbreaking in vivo and ex vivo cell and gene therapies.

‘Syngoi Technologies’:  Columbus VP creates a new company in Bizkaia for synthetic DNA production

‘Syngoi Technologies’: Columbus VP creates a new company in Bizkaia for synthetic DNA production

Columbus VP, a venture capital investment management company with a singular focus on business opportunities emerging in the biotechnology and life sciences sector.

Columbus launches a €70 million fund for biomedicine

Columbus launches a €70 million fund for biomedicine

With the new investment fund, the managers plan to build two new plants in San Sebastian

Follow us

Specialized channels and daily news on our social profiles.